New TET2 gene mutations in patients with myeloproliferative neoplasms and splanchnic vein thrombosis.

Suppr

超能文献

作者信息

Colaizzo D, Tiscia G L, Pisanelli D, Bafunno V, Amitrano L, Grandone E, Guardascione M A, Margaglione M

出版信息

J Thromb Haemost. 2010 May;8(5):1142-4. doi: 10.1111/j.1538-7836.2010.03810.x. Epub 2010 Feb 12.

DOI:10.1111/j.1538-7836.2010.03810.x

PMID:20156304

Abstract

摘要

相似文献

New TET2 gene mutations in patients with myeloproliferative neoplasms and splanchnic vein thrombosis.

J Thromb Haemost. 2010 May;8(5):1142-4. doi: 10.1111/j.1538-7836.2010.03810.x. Epub 2010 Feb 12.

TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms.

Ann Hematol. 2012 Apr;91(4):533-41. doi: 10.1007/s00277-011-1330-0. Epub 2011 Sep 9.

TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings.

Biomed Res Int. 2013;2013:929840. doi: 10.1155/2013/929840. Epub 2013 May 25.

Roles of IDH1/2 and TET2 mutations in myeloid disorders.

Int J Hematol. 2016 Jun;103(6):627-33. doi: 10.1007/s12185-016-1973-7. Epub 2016 Mar 15.

Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms.

Am J Hematol. 2010 Jan;85(1):81-3. doi: 10.1002/ajh.21562.

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.

Leukemia. 2010 May;24(5):1094-6. doi: 10.1038/leu.2010.52. Epub 2010 Apr 8.

TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosis.

Br J Haematol. 2014 May;165(3):416-9. doi: 10.1111/bjh.12738. Epub 2014 Jan 16.

The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.

Haematologica. 2011 Mar;96(3):367-74. doi: 10.3324/haematol.2010.034488. Epub 2010 Dec 20.

Cancer evolution constrained by mutation order.

N Engl J Med. 2015 Feb 12;372(7):661-3. doi: 10.1056/NEJMe1414288.

Mutation in TET2 in myeloid cancers.

N Engl J Med. 2009 Sep 10;361(11):1117; author reply 1117-8. doi: 10.1056/NEJMc091348.

引用本文的文献

Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights.

Int J Mol Sci. 2024 Jan 26;25(3):1524. doi: 10.3390/ijms25031524.

Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.

Ann Hematol. 2023 Jun;102(6):1409-1420. doi: 10.1007/s00277-023-05217-2. Epub 2023 Apr 20.

Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.

Diagnostics (Basel). 2023 Jan 3;13(1):163. doi: 10.3390/diagnostics13010163.

Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.

Ther Adv Hematol. 2017 Mar;8(3):107-118. doi: 10.1177/2040620716680333. Epub 2016 Dec 8.

The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development.

Oncotarget. 2016 Sep 27;7(39):64512-64525. doi: 10.18632/oncotarget.11412.

Alterations of 5-hydroxymethylcytosine in human cancers.

Cancers (Basel). 2013 Jun 25;5(3):786-814. doi: 10.3390/cancers5030786.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验